Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-to-moderate open-angle glaucoma. The company's product pipeline includes iStent Infinite, a three stents product that is designed for use as a standalone procedure in patients with refractory glaucoma; and iDose TR, a targeted injectable implant based on its micro-scale device-platform that is designed to deliver therapeutic levels of medication. The company markets its products through direct sales organization, as well as through distributors in the United States and internationally. Glaukos Corporation was incorporated in 1998 and is headquartered in San Clemente, California.
Over the last 12 months, insiders at Glaukos Corporation have bought $0 and sold $61.86M worth of Glaukos Corporation stock.
On average, over the past 5 years, insiders at Glaukos Corporation have bought $0 and sold $20.27M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 4,200 shares for transaction amount of $100,128 was made by Gilliam Joseph E () on 2017‑11‑22.
2024-10-30 | Sale | PRESIDENT & COO | 2,275 0.0041% | $138.97 | $316,157 | +1.30% | ||
2024-09-09 | Sale | director | 3,000 0.0055% | $130.67 | $392,000 | +2.28% | ||
2024-08-21 | Sale | PRESIDENT & COO | 5,000 0.0091% | $129.36 | $646,791 | +1.93% | ||
2024-08-15 | Sale | director | 6,250 0.0118% | $125.93 | $787,086 | 0.00% | ||
2024-08-08 | Sale | director | 25,000 0.0453% | $120.00 | $3M | +9.39% | ||
2024-07-05 | Sale | PRESIDENT & COO | 2,250 0.0046% | $121.39 | $273,128 | 0.00% | ||
2024-06-03 | Sale | PRESIDENT & COO | 2,500 0.0049% | $113.50 | $283,751 | +12.27% | ||
2024-05-30 | Sale | director | 5,000 0.01% | $112.00 | $560,000 | +15.75% | ||
2024-05-15 | Sale | director | 6,250 0.0126% | $112.80 | $704,993 | +14.59% | ||
2024-05-10 | Sale | PRESIDENT & COO | 2,395 0.0048% | $110.56 | $264,791 | +14.84% | ||
2024-05-10 | Sale | SVP & CHIEF FINANCIAL OFFICER | 316 0.0006% | $110.43 | $34,896 | +14.84% | ||
2024-05-10 | Sale | SVP & CHIEF FINANCIAL OFFICER | 353 0.0007% | $110.51 | $39,011 | +14.84% | ||
2024-05-06 | Sale | PRESIDENT & COO | 105 0.0002% | $110.36 | $11,588 | +20.49% | ||
2024-05-06 | Sale | SVP & CHIEF FINANCIAL OFFICER | 90 0.0002% | $110.26 | $9,923 | +20.49% | ||
2024-05-02 | Sale | PRESIDENT & COO | 2,059 0.0041% | $105.52 | $217,263 | +20.29% | ||
2024-05-02 | Sale | SVP & CHIEF FINANCIAL OFFICER | 442 0.0009% | $105.69 | $46,713 | +20.29% | ||
2024-04-08 | Sale | PRESIDENT & COO | 59,801 0.1207% | $100.47 | $6.01M | +21.77% | ||
2024-04-08 | Sale | SVP & CHIEF FINANCIAL OFFICER | 1,372 0.0028% | $100.54 | $137,944 | +21.77% | ||
2024-04-05 | Sale | PRESIDENT & COO | 2,457 0.005% | $96.81 | $237,862 | +26.39% | ||
2024-04-05 | Sale | SVP & CHIEF FINANCIAL OFFICER | 262 0.0005% | $96.63 | $25,316 | +26.39% |
Gilliam Joseph E | PRESIDENT & COO | 102169 0.1853% | $139.66 | 1 | 39 | +49.43% |
Burns Thomas William | CHAIRMAN & CEO | 55835 0.1013% | $139.66 | 1 | 45 | +18.1% |
Thurman Alex R. | SVP & CHIEF FINANCIAL OFFICER | 51647 0.0937% | $139.66 | 0 | 14 | |
Stapley Marc | director | 34076 0.0618% | $139.66 | 0 | 4 | |
Foley Mark J | director | 33220 0.0602% | $139.66 | 0 | 1 | |
Kliman Gilbert H | director | 32336 0.0586% | $139.66 | 0 | 9 | |
WEISNER AIMEE S | director | 30119 0.0546% | $139.66 | 2 | 1 | +57.32% |
MONTREUX EQUITY PARTNERS IV LP | 10 percent owner | 3209812 5.8215% | $139.66 | 0 | 1 | |
Calcaterra Chris M. | Chief Operating Officer | 163806 0.2971% | $139.66 | 0 | 15 | |
VERSANT VENTURES I LLC | 51247 0.0929% | $139.66 | 0 | 1 | ||
LINK WILLIAM J PHD | director | 15439 0.028% | $139.66 | 0 | 5 | |
MORE ROBERT J | director | 5000 0.0091% | $139.66 | 1 | 0 | |
HARRISON RICHARD L | 1388 0.0025% | $139.66 | 1 | 8 | +18.1% | |
ORBIMED ADVISORS LLC | director | 0 0% | $139.66 | 0 | 17 | |
SILVERSTEIN JONATHAN | director | 0 0% | $139.66 | 0 | 17 |
BlackRock | $744.61M | 15.68 | 7.9M | +0.03% | +$255,997.35 | 0.02 | |
Fidelity Investments | $693.68M | 14.61 | 7.36M | +26.43% | +$145M | 0.05 | |
The Vanguard Group | $500.58M | 10.54 | 5.31M | +1.38% | +$6.8M | 0.01 | |
Brown Capital Management | $201.11M | 4.24 | 2.13M | -20.94% | -$53.27M | 3.57 | |
State Street | $172.15M | 3.63 | 1.83M | +0.48% | +$829,657.71 | 0.01 | |
Janus Henderson | $151.89M | 3.2 | 1.61M | -0.35% | -$532,353.51 | 0.08 | |
Invesco | $151.26M | 3.19 | 1.6M | +2.01% | +$2.97M | 0.03 | |
Lord Abbett | $142.75M | 3.01 | 1.51M | +213.55% | +$97.22M | 0.5 | |
Ameriprise Financial | $137.61M | 2.9 | 1.46M | +28.4% | +$30.43M | 0.04 | |
Millennium Management LLC | $125.15M | 2.64 | 1.33M | +29.7% | +$28.66M | 0.08 | |
Alger | $116.11M | 2.45 | 1.23M | -25.15% | -$39M | 0.58 | |
Artisan Partners | $115.31M | 2.43 | 1.22M | 0% | +$0 | 0.17 | |
Geode Capital Management | $97.88M | 2.06 | 1.04M | +2.97% | +$2.82M | 0.01 | |
Dimensional Fund Advisors | $86.57M | 1.82 | 918,156 | -0.58% | -$506,337.30 | 0.02 | |
PRIMECAP Management Co | $80.02M | 1.69 | 848,635 | +7.42% | +$5.53M | 0.06 | |
Driehaus Capital Management LLC | $61.1M | 1.29 | 647,997 | +10.04% | +$5.58M | 0.61 | |
Morgan Stanley | $51.96M | 1.09 | 551,024 | -16.8% | -$10.49M | <0.01 | |
Capital World Investors | $51.89M | 1.09 | 550,322 | 0% | +$0 | 0.01 | |
Riverbridge Partners | $50.4M | 1.06 | 534,514 | -2.48% | -$1.28M | 0.62 | |
Northern Trust | $50.24M | 1.06 | 532,817 | -1.82% | -$932,622.41 | 0.01 | |
New York State Common Retirement Fund | $48.53M | 1.02 | 514,730 | +0.33% | +$160,387.65 | 0.07 | |
Braidwell Lp | $42.49M | 0.9 | 450,676 | +85.65% | +$19.6M | 2.41 | |
Iron Triangle Partners LP | $40.5M | 0.85 | 429,525 | +75.6% | +$17.44M | 4.31 | |
Loomis, Sayles & Company | $40.05M | 0.84 | 424,724 | -2.64% | -$1.09M | 0.06 | |
American Century Investments | $39.94M | 0.84 | 423,566 | -0.15% | -$58,648.38 | 0.03 | |
Wellington Management Company | $39.82M | 0.84 | 422,282 | -68.5% | -$86.58M | 0.01 | |
Charles Schwab | $38.43M | 0.81 | 407,535 | +3.9% | +$1.44M | 0.01 | |
Gilder Gagnon Howe & Co. LLC | $38.03M | 0.8 | 403,308 | +361.13% | +$29.78M | 0.49 | |
BNY Mellon | $36.51M | 0.77 | 387,170 | -5.71% | -$2.21M | 0.01 | |
Nuveen | $31.99M | 0.67 | 339,361 | -8.44% | -$2.95M | 0.01 | |
Bank of America | $27.34M | 0.58 | 290,000 | -21.91% | -$7.67M | <0.01 | |
Goldman Sachs | $21.73M | 0.46 | 230,420 | +81.95% | +$9.79M | <0.01 | |
Avidity Partners Management Lp | $21.12M | 0.45 | 224,000 | New | +$21.12M | 0.8 | |
Adage Capital Partners Gp L L C | $18.86M | 0.4 | 200,000 | 0% | +$0 | 0.03 | |
Royal Bank of Canada | $18.65M | 0.39 | 197,810 | -21.62% | -$5.14M | <0.01 | |
C Worldwide Group Holding A S | $18.59M | 0.39 | 197,212 | 0% | +$0 | 0.21 | |
Nomura Holdings | $18.29M | 0.39 | 193,994 | -16.39% | -$3.59M | 0.16 | |
Atika Capital Management Llc | $16.5M | 0.35 | 175,000 | +40.04% | +$4.72M | 1.97 | |
Allspring Global Investments | $15.66M | 0.33 | 166,054 | +127.54% | +$8.78M | 0.03 | |
Renaissance Technologies | $14.9M | 0.31 | 157,992 | -4.65% | -$726,029.80 | 0.02 | |
KeyBank | $13.42M | 0.28 | 142,358 | -0.06% | -$7,920.36 | 0.05 | |
Legal & General | $13.21M | 0.28 | 140,104 | +4.27% | +$541,130.26 | <0.01 | |
RhumbLine Advisers | $12.82M | 0.27 | 136,012 | -1.49% | -$193,388.29 | 0.01 | |
Polar Asset Management Partners Inc | $10.95M | 0.23 | 116,136 | +274.2% | +$8.02M | 0.22 | |
Man Group Plc | $10.81M | 0.23 | 114,696 | -45.83% | -$9.15M | 0.03 | |
Cubist Systematic Strategies | $10.63M | 0.22 | 112,718 | -40.52% | -$7.24M | 0.09 | |
Segall Bryant & Hamill | $10.12M | 0.21 | 107,282 | +20.82% | +$1.74M | 0.19 | |
Connor Clark & Lunn Investment Management Ltd | $9.52M | 0.2 | 100,936 | +3.21% | +$295,787.72 | 0.02 | |
Public Sector Pension Investment Board | $9.43M | 0.2 | 100,032 | -1.06% | -$100,890.30 | 0.07 | |
PEREGRINE CAPITAL MANAGEMENT INC | $9.25M | 0.2 | 98,140 | -0.96% | -$89,669.79 | 0.27 |